Principal Financial Group Inc Adicet Bio, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$1.76 - $3.45 $5,102 - $10,001	2,899 Added 24.64%	14,664 $34,000
Q4 2023 Feb 07, 2024	SELL	$1.11 - $1.89 $1,032 - $1,757	-930 Reduced 7.33%	11,765 $22,000
Q2 2023 Aug 07, 2023	SELL	$2.13 - $7.13 $7,823 - $26,188	-3,673 Reduced 22.44%	12,695 $30,000
Q1 2023 May 09, 2023	SELL	$5.52 - $9.23 $2,743 - $4,587	-497 Reduced 2.95%	16,368 $94,000
Q4 2022 Feb 09, 2023	BUY	$7.72 - $21.27 $130,197 - $358,718	16,865 New	16,865 $150,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.